ArticleFrontiers in global women's health2025
Status and innovation needed to address health disparities in opioid use disorders among hispanic pregnant individuals.
Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Opportunities to sustain matricentric models of community and person-centered care for perinatal substance use in the postFrontiers in psychiatry · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although opioid use disorder (OUD) in pregnancy has increased significantly in the last years, there are still significant gaps in scientific data and in access to evidence-based treatments. OUD in pregnancy is associated with negative health outcomes in the pregnant person, the fetus, and the newborn. To prevent these consequences, it is imperative to identify OUD and provide treatment as soon as possible in the pregnancy. Effective treatments, such as medication for opioid use disorder (MOUD), are safe in pregnancy but not routinely prescribed. For Hispanic pregnant people, these evidence-based treatments are less likely to be prescribed, are less consistently used and are less likely to be continued during the first year postpartum. Increasing access to high quality evidence-based treatments for OUD in Hispanic pregnant people is a public health emergency. This article will offer an overview of the known health disparities of treating perinatal OUD in Hispanics and propose strategies to address these disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.